Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

SK-951 demonstrates advantages over cisapride in models of impaired gastric emptying

Dec. 21, 1999

ViroPharma and Wyeth-Ayerst form alliance to develop HCV drugs

Dec. 16, 1999

Infliximab now available in U.K. through Centocor licensee

Dec. 16, 1999

InKine initiates phase II multicenter trial for IBD treatment

Dec. 15, 1999

Role for antioxidant in the treatment of ulcers: experimental results presented at Indian congress

Dec. 15, 1999

Nippon Chemiphar withdraws Leminon 80 application for approval in Japan

Dec. 15, 1999

Medivir investigates new treatments for hepatitis B

Dec. 13, 1999

Clinical development of ISIS-2302 progresses steadily

Dec. 10, 1999

AVI and XTL collaborate on HBV and HCV treatments

Dec. 10, 1999

Pyridazinone cell adhesion inhibitors investigated as promising antiinflammatory agents

Dec. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...